Abstract
P. falciparum causes the most severe form of malaria in younger children and pregnant women. In vitro culture systems allow researchers to understand parasite biology, elucidate mechanism of host immunity and test efficacy of antimalarial agents or vaccines in preclinical studies. Most laboratory-adapted parasite strains predate the emergence of artemisinin-based drug combinations and mainly originate from Asia or Europe. To fully understand the biochemical and phenotypic characteristics of parasites, it is imperative that researchers are able to culture parasites circulating in an area to unravel any geographical differences at the population level. Ex vivo culturing of clinical isolates can be challenging when collecting samples in the field and requires technical expertise and equipment. To overcome this challenge, clinical isolates are cryopreserved in the field and transported to a laboratory for in vitro studies. In this protocol, we describe different methods of cryopreserving P. falciparum isolates in the field and thawing them for subsequent in vitro culture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Knowles R, Gupta BMD (1932) A study of monkey-malaria, and its experimental transmission to man. Ind Med Gaz 67(6):301–320
Schimdt LH, Greenland R, Genther CS (1961) The transmission of plasmodium cynomolgi to man. Am J Trop Med Hyg 10:679–688
Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193(4254):673–675. https://doi.org/10.1126/science.781840
Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot TR, Carter R (1987) Genetic analysis of the human malaria parasite plasmodium falciparum. Science 236(4809):1661–1666. https://doi.org/10.1126/science.3299700
Oduola AMJ, Milhous WK, Weatherly NF, Bowdre JH, Desjardins RE (1988) Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Exp Parasitol 67(2):354–360. https://doi.org/10.1016/0014-4894(88)90082-3
Rosario V (1981) Cloning of naturally occurring mixed infections of malaria parasites. Science 212(4498):1037–1038. https://doi.org/10.1126/science.7015505
Draper SJ, Angov E, Horii T, Miller LH, Srinivasan P, Theisen M, Biswas S (2015) Recent advances in recombinant protein-based malaria vaccines. Vaccine 33(52):7433–7443. https://doi.org/10.1016/j.vaccine.2015.09.093
Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labbe GM, Alanine DG, Siani L, Di MS RR, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, JS MC, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ (2017) Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI Insight 2(21):e96381. https://doi.org/10.1172/jci.insight.96381
Coelho C, Doritchamou J, Zaidi I, Duffy P (2017) Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium. NPJ Vaccines 2:34. https://doi.org/10.1038/s41541-017-0035-3
RTS,S Clinical Trials Partnership (2015) Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386(9988):31–45. https://doi.org/10.1016/S0140-6736(15)60721-8
RTS,S Clinical Trials Partnership, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BGNO, Kabwende AL, Adegnika AA, Mordmüller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Bihoun B, Guiraud I, Kaboré B, Sombié O, Guiguemdé RT, Ouédraogo JB, Hamel MJ, Kariuki S, Oneko M, Odero C, Otieno K, Awino N, McMorrow M, Muturi-Kioi V, Laserson KF, Slutsker L, Otieno W, Otieno L, Otsyula N, Gondi S, Otieno A, Owira V, Oguk E, Odongo G, Woods JB, Ogutu B, Njuguna P, Chilengi R, Akoo P, Kerubo C, Maingi C, Lang T, Olotu A, Bejon P, Marsh K, Mwambingu G, Owusu-Agyei S, Asante KP, Osei-Kwakye K, Boahen O, Dosoo D, Asante I, Adjei G, Kwara E, Chandramohan D, Greenwood B, Lusingu J, Gesase S, Malabeja A, Abdul O, Mahende C, Liheluka E, Malle L, Lemnge M, Theander TG, Drakeley C, Ansong D, Agbenyega T, Adjei S, Boateng HO, Rettig T, Bawa J, Sylverken J, Sambian D, Sarfo A, Agyekum A, Martinson F, Hoffman I, Mvalo T, Kamthunzi P, Nkomo R, Tembo T, Tegha G, Tsidya M, Kilembe J, Chawinga C, Ballou WR, Cohen J, Guerra Y, Jongert E, Lapierre D, Leach A, Lievens M, Ofori-Anyinam O, Olivier A, Vekemans J, Carter T, Kaslow D, Leboulleux D, Loucq C, Radford A, Savarese B, Schellenberg D, Sillman M, Vansadia P (2012) A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 367(24):2284–2295. https://doi.org/10.1056/NEJMoa1208394
Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M, Kaslow DC, Njuguna P, Marsh K, Bejon P (2016) Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children. N Engl J Med 374(26):2519–2529. https://doi.org/10.1056/NEJMoa1515257
Adepoju P (2019) RTS,S malaria vaccine pilots in three African countries. Lancet 393(10182):1685. https://doi.org/10.1016/s0140-6736(19)30937-7
Tarr SJ, DÃaz-Ingelmo O, Stewart LB, Hocking SE, Murray L, Duffy CW, Otto TD, Chappell L, Rayner JC, Awandare GA, Conway DJ (2018) Schizont transcriptome variation among clinical isolates and laboratory-adapted clones of the malaria parasite plasmodium falciparum. BMC Genomics 19(1):894. https://doi.org/10.1186/s12864-018-5257-x
Chirawurah JD, Ansah F, Nyarko PB, Duodu S, Aniweh Y, Awandare GA (2017) Antimalarial activity of malaria box compounds against plasmodium falciparum clinical isolates. Int J Parasitol Drugs Drug Resist 7(3):399–406. https://doi.org/10.1016/j.ijpddr.2017.10.005
Langreth SG, Reese RT (1979) Antigenicity of the infected-erythrocyte and merozoite surfaces in falciparum malaria. J Exp Med 150(5):1241–1254. https://doi.org/10.1084/jem.150.5.1241
Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold CI, Miller LH (1995) Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82(1):101–110. https://doi.org/10.1016/0092-8674(95)90056-x
Jensen AR, Adams Y, Hviid L (2020) Cerebral plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol Rev 293(1):230–252. https://doi.org/10.1111/imr.12807
Boyle MJ, Wilson DW, Richards JS, Riglar DT, Tetteh KKA, Conway DJ, Ralph SA, Baum J, Beeson JG (2010) Isolation of viable plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc Natl Acad Sci U S A 107(32):14378–14383. https://doi.org/10.1073/pnas.1009198107
Dutta S, Haynes JD, Moch JK, Barbosa A, Lanar DE (2003) Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of plasmodium falciparum merozoites. Proc Natl Acad Sci U S A 100(21):12295–12300. https://doi.org/10.1073/pnas.2032858100
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Partey, F.D., Frimpong, A., Ofori, M.F. (2022). Collection and Cryopreservation of Plasmodium falciparum Clinical Isolates in the Field. In: Jensen, A.T.R., Hviid, L. (eds) Malaria Immunology. Methods in Molecular Biology, vol 2470. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2189-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2189-9_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2188-2
Online ISBN: 978-1-0716-2189-9
eBook Packages: Springer Protocols